BTK and myeloid sarcoma: We demonstrate that cellular metabolic pathways are involved in distinct functions of human B cells and highlight targeting of cellular metabolism, and particularly inhibition of mitochondrial respiration, as an approach for limiting pro-inflammatory activation of both B cells and T cells, and as a potential contributor to the therapeutic effects of BTK inhibition in MS.